Condition: Ulcerative Colitis · Crohn Disease · Sponsor: University of California, San Diego
The purpose of this study is to compare the effectiveness and safety of a strategy of switching to an alternative targeted immunomodulator (TIM) therapy to treat to a target of endoscopic remission, versus continuing index TIM in patients with inflammatory bowel disease (IBD) (Crohn's disease or ulcerative colitis \[UC\]) in symptomatic remission with moderate to severe endoscopic inflammation despite optimization of index TIM in a real-world setting.
This description comes directly from the study's public registry record.
Siddharth Singh, MD · 858-246-2352 · sis040@health.ucsd.edu
Jason Hou, MD · 713-798-8220 · jkhou@bcm.edu
Always discuss trial participation with your own doctor first.
| Hoag Hospital | Irvine, California, United States | Recruiting |
| UC San Diego Health | La Jolla, California, United States | Recruiting |
| Cedars-Sinai | Los Angeles, California, United States | Recruiting |
| Sutter Health | Palo Alto, California, United States | Recruiting |
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| University of Chicago Medicine | Chicago, Illinois, United States | Recruiting |
| Dartmouth Hitchcock | Lebanon, New Hampshire, United States | Recruiting |
| Saratoga Schenectady Gastroenterology Associates | Burnt Hills, New York, United States | Recruiting |
| NYU Langone Health | New York, New York, United States | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05230173